NO942707L - Syntetiske peptider egnet for vaksine mot rubellsinfeksjoner - Google Patents
Syntetiske peptider egnet for vaksine mot rubellsinfeksjonerInfo
- Publication number
- NO942707L NO942707L NO942707A NO942707A NO942707L NO 942707 L NO942707 L NO 942707L NO 942707 A NO942707 A NO 942707A NO 942707 A NO942707 A NO 942707A NO 942707 L NO942707 L NO 942707L
- Authority
- NO
- Norway
- Prior art keywords
- rubella
- synthetic peptides
- peptides suitable
- vaccine
- protein
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 201000005404 rubella Diseases 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title 1
- 241000710799 Rubella virus Species 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 101710117545 C protein Proteins 0.000 abstract 1
- 101710125507 Integrase/recombinase Proteins 0.000 abstract 1
- 101710185720 Putative ethidium bromide resistance protein Proteins 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 125000003473 lipid group Chemical group 0.000 abstract 1
- 229960003131 rubella vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36211—Rubivirus, e.g. rubella virus
- C12N2770/36222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Syntetiske peptider har en aminosyresekvens som tilsva- rer minst en antigen determinant av minst et protein vanligvis et strukturert protein, spesielt El, E2 eller C-proteinene, hos rubella-virus (RV) blir brukt som sådan i hybrid eller kimerisk tandem T-B-form, i lipi- dert form, bundet til et bærermolekyl og/eller poly- merisert for å danne molekylære aggregater i vaksiner mot rubella. Analoger av peptider som er humane T-celle determinanter blir brukt til å behandle rubella-assosi- erte autoimmune sykdommer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929201139A GB9201139D0 (en) | 1992-01-20 | 1992-01-20 | Synthetic peptides for a rubella vaccine |
PCT/CA1993/000014 WO1993014206A2 (en) | 1992-01-20 | 1993-01-20 | Synthetic peptides for a rubella vaccine |
Publications (2)
Publication Number | Publication Date |
---|---|
NO942707D0 NO942707D0 (no) | 1994-07-19 |
NO942707L true NO942707L (no) | 1994-09-20 |
Family
ID=10708876
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO942707A NO942707L (no) | 1992-01-20 | 1994-07-19 | Syntetiske peptider egnet for vaksine mot rubellsinfeksjoner |
Country Status (10)
Country | Link |
---|---|
US (1) | US6037448A (no) |
EP (1) | EP0624198A1 (no) |
JP (1) | JPH07503133A (no) |
AU (1) | AU662954B2 (no) |
CA (1) | CA2128407C (no) |
FI (1) | FI943418A (no) |
GB (1) | GB9201139D0 (no) |
NO (1) | NO942707L (no) |
RU (1) | RU94040393A (no) |
WO (1) | WO1993014206A2 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5427792A (en) * | 1989-08-23 | 1995-06-27 | Biochem Immunosystems, Inc. | Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus |
AU1749597A (en) * | 1996-01-19 | 1997-08-11 | Virginia Mason Research Center | Allele-specific peptide epitope strategy for vaccine development |
CA2238660A1 (en) * | 1998-05-22 | 1999-11-22 | Janet Chantler | Gene sequences of rubella virus associated with attenuation |
SE9903031D0 (sv) * | 1999-08-27 | 1999-08-27 | Eurodiagnostica Ab | Peptide mixture and vaccine against a chronic viral infection |
EP1432729B1 (en) * | 2001-07-02 | 2008-11-12 | Merrion Research III Limited | Peyers's patch and/or m-cell targeting ligands |
HUE025149T2 (hu) | 2007-08-02 | 2016-01-28 | Biondvax Pharmaceuticals Ltd | Multimer multiepitóp influenza vakcinák |
US9303070B2 (en) | 2011-02-22 | 2016-04-05 | Biondvax Pharmaceuticals Ltd. | Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines |
EP3077410B1 (en) * | 2013-12-03 | 2021-02-03 | Virometix AG | Proline-rich peptides protective against s. pneumoniae |
CN107098980A (zh) * | 2017-06-28 | 2017-08-29 | 潍坊汉唐生物工程有限公司 | 一种检测风疹病毒抗体的融合蛋白及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2206587A (en) * | 1987-07-08 | 1989-01-11 | London Biotechnology Ltd | Rubella e1 glycoprotein antigens |
US5164481A (en) * | 1989-08-23 | 1992-11-17 | Iaf Biochem International Inc. | Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus |
-
1992
- 1992-01-20 GB GB929201139A patent/GB9201139D0/en active Pending
-
1993
- 1993-01-20 JP JP5512042A patent/JPH07503133A/ja active Pending
- 1993-01-20 CA CA002128407A patent/CA2128407C/en not_active Expired - Lifetime
- 1993-01-20 EP EP93901999A patent/EP0624198A1/en not_active Withdrawn
- 1993-01-20 WO PCT/CA1993/000014 patent/WO1993014206A2/en not_active Application Discontinuation
- 1993-01-20 US US08/256,747 patent/US6037448A/en not_active Expired - Lifetime
- 1993-01-20 AU AU33413/93A patent/AU662954B2/en not_active Ceased
- 1993-01-20 RU RU94040393/13A patent/RU94040393A/ru unknown
-
1994
- 1994-07-19 NO NO942707A patent/NO942707L/no unknown
- 1994-07-19 FI FI943418A patent/FI943418A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2128407C (en) | 2002-04-09 |
AU662954B2 (en) | 1995-09-21 |
WO1993014206A2 (en) | 1993-07-22 |
EP0624198A1 (en) | 1994-11-17 |
CA2128407A1 (en) | 1993-07-22 |
AU3341393A (en) | 1993-08-03 |
FI943418A (fi) | 1994-09-15 |
JPH07503133A (ja) | 1995-04-06 |
NO942707D0 (no) | 1994-07-19 |
WO1993014206A3 (en) | 1993-10-28 |
RU94040393A (ru) | 1996-11-10 |
FI943418A0 (fi) | 1994-07-19 |
US6037448A (en) | 2000-03-14 |
GB9201139D0 (en) | 1992-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO913518L (no) | Vaksiner for ikke typebestembar haemophilus influenzae. | |
AU591054B2 (en) | Pre-S gene coded peptide hepatitis B immunogens, vaccines and diagnostics | |
DK0587780T3 (da) | Smitstof, som forårsager Mystery Swine Disease, vaccinepræparater og diagnostiske sæt | |
GB2255093A (en) | Hiv-1 core protein fragments | |
EP0243913A3 (en) | Pre-s gene codes peptide hepatitis b immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers | |
NO942707L (no) | Syntetiske peptider egnet for vaksine mot rubellsinfeksjoner | |
DE68925660D1 (de) | Peptidfragmente von HIV | |
DK0661999T3 (da) | Vacciner mod felint immundefekt virus (FIV) | |
ATE298798T1 (de) | Fusionsproteine zwischen antigene aminosäuresequenzen und beta - 2- mikroglobulin | |
NO319525B1 (no) | Fremgangsmate for a danne et konjugat av et helt hemagglutinin,HA, protein av influensavirus samt fremgangsmate for fremstilling av et immunologisk preparat omfattende konjugatet. | |
ATE162550T1 (de) | Ospc-antigen-impfstoffe immunogene zusammensetzung zur vorbeugung und behandlung von lyme-krankheit und rekombinante verfahren zur herstellung von derartige antigene | |
ATA171686A (de) | Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen | |
ATE221786T1 (de) | Synthetischer impfstoff zum schutz gegen infektionen mit dem menschlichen immunschwächevirus | |
CA2521038A1 (en) | Polypeptide comprising cell adhesion motif, t cell epitope and b cell epitope for inducing antibody production | |
AU4712993A (en) | New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods | |
BRPI0009746B8 (pt) | molécula de veículo contendo plasmídeo pg-pviii compreendendo uma seqúência que codifica uma parte de uma glicoproteína de lissavírus contendo pelo menos o sítio iii da glicoproteína de lissavírus mas não contendo o sítio ii, e, composição imunogênica | |
Balasa et al. | Immunotargeting of thyroglobulin on antigen presenting cells abrogates natural tolerance in the absence of adjuvant | |
KR950701821A (ko) | 피임 백신(contraceptive vaccine) | |
Rajnavölgyi | Synthetic peptides in the search for T-and B-cell epitopes | |
NZ331889A (en) | Trypanosomatids histones for use as an antigen against trypanosomatic infection, including diagnostic tests, pharmaceutical compositions and vaccines of these antigens | |
BR9711809A (pt) | Polipeptìdeo antigênico ou imunogênico, processos para tratar ou prevenir uma doença ou distúrbio em um indivìduo provocado por infecção com htlv-i, e com htlv-ii, para elicitar em um indivìduo a produção de anticorpos que especificamente ligam-se às proteìnas envelopes htlv-ii e htlv-i, e, para gerar uma resposta imune em um indivìduo | |
SE9202318D0 (sv) | Nya peptider, diagnostiska antigen, anvaendning daerav, vacciner och medikamenter | |
ES1027961U (es) | Soporte publicitario para carritos. | |
ES2065254A1 (es) | Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados. |